logo

Quick Facts

Share SHARE

CryoLife, Inc. (CRY), a medical device and tissue processing company focused on cardiac surgery, announced, for 2016, the company now expects non-GAAP income per share in a range of $0.32 - $0.34, compared to prior guidance range of $0.29 - $0.32. The company now projects 2016 total revenues in a range...

Crane Co. (CR), a diversified manufacturer of highly engineered industrial products, announced the company is raising 2016 GAAP EPS guidance to a range of $3.95-$4.15, versus a prior range of $3.85-$4.15. Excluding Special Items, EPS is now expected to be in a range of $4.00-$4.20, from the prior range...

Cadence Design Systems, Inc. (CDNS) announced, for the third quarter of 2016, the company expects total revenue in the range of $440 million to $450 million. Third quarter non-GAAP net income per share is expected to be in the range of $0.27 to $0.29. Analysts polled by Thomson Reuters expect the company...

Commerzbank Aktiengesellschaft (CRZBY.PK) reported that, on the basis of preliminary figures, second-quarter net profit attributable to shareholders decreased to 209 million euros from 307 million euros, previous year. Operating profit was 342 million euros compared to 419 million euros. The Common...

Express Scripts Holding Company (ESRX) narrowed 2016 adjusted earnings per share guidance to a range of $6.33 to $6.43, from a range of $6.31 to $6.43. Th revised guidance raises the mid-point from $6.37 to $6.38. The increased adjusted earnings per share guidance range represents growth of 14% to 16%...

Gilead Sciences, Inc. (GILD) announced the company now expects EPS Impact of acquisition-related, up-front collaboration, stock-based compensation and other expenses to be in the range of $1.47 - $1.53 for the full year 2016, up from the previously projected range of $1.10 - $1.16. For 2016, the...

Boeing (BA) released its 2016 Pilot and Technician Outlook today at EAA AirVenture Oshkosh and projects a demand for nearly 1.5 million pilots and technicians over the next 20 years. Boeing forecasts that between 2016 and 2035, the world's commercial aviation industry will require approximately 617,000...

Baidu Inc. (BIDU), Chinese language Internet search provider, announced that the special committee of the Company's board of directors received a letter from Mr. Robin Yanhong Li, chairman and chief executive officer of Baidu, and Mr. Yu Gong, chief executive officer of Qiyi.com, Inc., who led a consortium...

National Interstate Corp. (NATL) said it has agreed to be acquired Great American Insurance Co., a wholly-owned subsidiary of American Financial Group, Inc. (AFG). Under the deal, Great American will acquire the approximately 49 percent of the company's issued and outstanding common shares that Great...

Netflix (NFLX) and 20th Century Fox Television Distribution announced first global SVOD licensing agreement. Netflix will be the exclusive global streaming home for FX's hit, American Crime Story. The first season of the franchise will be available globally on Netflix, excluding Canada, in 2017 with...

Outerwall Inc. (OUTR) said that it has entered into an Agreement and Plan of Merger with affiliates of certain funds managed by affiliates of Apollo Global Management, LLC (APO), a leading global alternative investment manager, pursuant to which the Apollo Funds will acquire all of the outstanding shares...

Spark Therapeutics (ONCE) and Pfizer Inc. (PFE) announced updated results of the first cohort from the ongoing Phase 1/2 clinical trial of SPK-9001, the lead investigational candidate in the companies' SPK-FIX program, in development for the treatment of hemophilia B as a potential one-time therapy....

CVS Health (CVS) announced that the opioid overdose-reversal medication naloxone is now available without a prescription at all CVS Pharmacy locations in Texas. CVS Health has established a standing order with physicians in Texas that allows CVS Pharmacy to expand access to the medication across the...

Alder BioPharmaceuticals, Inc. (ALDR) Monday announced positive data in a 24-week phase 2b trial with its monoclonal antibody product candidate ALD403 in chronic migraine patients. ALD403 targets calcitonin gene-related peptide. Earlier in March, phase 2b study using 300 mg and 100 mg dose levels...

Skullcandy Inc. (SKUL) announced the expiration of the "go-shop" period pursuant to the terms of the previously announced definitive merger agreement pursuant to which Skullcandy has agreed to be acquired by a direct wholly-owned subsidiary of Incipio, LLC. Under the terms of the Merger Agreement, Skullcandy...

Follow RTT